Lipopolysaccharides. Lipoglycans . Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) . 1.00
Lipopolysaccharide Receptors. CD14 Antigen . CD14 Monocyte Differentiation Antigen . LPS Receptor . Lipoglycan Receptor . Receptor, LPS . Receptor, Lipoglycan . Antigens, CD14 . CD14 Antigens . Receptors, Lipopolysaccharide . Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein. . 0.82
Mucolipidoses. Cherry Red Spot-Myoclonus Syndrome . Deficiency Disease, Ganglioside Sialidase . Glycoprotein Neuraminidase Deficiency . Inclusion Cell Disease . Mucolipidosis I . Mucolipidosis II . Mucolipidosis III . Mucolipidosis III Alpha Beta . Mucolipidosis IIIa . Mucolipidosis IV . Mucolipidosis Type 1 . Mucolipidosis Type I . Mucolipidosis Type II . Mucolipidosis Type III . Mucolipidosis Type IV . Myoclonus-Cherry Red Spot Syndrome . Psuedo-Hurler Disease . Sialolipidosis . Type I Mucolipidosis . Type II Mucolipidosis . Type III Mucolipidosis . Type IV Mucolipidosis . Deficiencies, Glycoprotein Neuraminidase . Deficiency, Glycoprotein Neuraminidase . Glycoprotein Neuraminidase Deficiencies . I Cell Disease . I-Cell Diseases . Inclusion Cell Diseases . Lipomucopolysaccharidoses . Mucolipidoses, Type I . Mucolipidoses, Type II . Mucolipidoses, Type III . Mucolipidoses, Type IV . Mucolipidosis, Type I . Mucolipidosis, Type II . Mucolipidosis, Type III . Mucolipidosis, Type IV . Polydystrophy, Pseudo-Hurler . Pseudo Hurler Polydystrophy . Psuedo Hurler Disease . Psuedo-Hurler Diseases . Sialidoses . Sialolipidoses . Type I Mucolipidoses . Type II Mucolipidoses . Type III Mucolipidoses . Type IV Mucolipidoses . I-Cell Disease . Lipomucopolysaccharidosis . Pseudo-Hurler Polydystrophy . Cherry Red Spot Myoclonus Syndrome . Ganglioside Sialidase Deficiency Disease . Mucolipidosis . Myoclonus Cherry Red Spot Syndrome . Sialidosis . A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) . 0.75
Glycosaminoglycans. Mucopolysaccharides . Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). . 0.67
Lipolysis. Lipolyses . The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. . 0.58
Fungal Polysaccharides. Polysaccharides, Fungal . Cell wall components constituting a polysaccharide core found in fungi. They may act as antigens or structural substrates. . 0.58
